<p>Representative pictures of immunocytochemistry for IL-33, ST2, MyD88 and IRAK-1 are presented (<b>A</b>). mRNA levels of IL-33, sST2 and ST2L in VSMCs stimulated with sST2 (2 µg/ml) (<b>B</b>). Protein levels of IL-33, ST2-L, MyD88 and IRAK-1 are shown (<b>C</b>). All conditions were performed at least by triplicate. Histogram bars represent the mean ± SEM of 4 assays, in arbitrary units normalized to HPRT and β-actin respectively for cDNA and protein. *p<0.05 <i>vs</i>. control.</p
Interleukin 33 (IL-33), which is expressed by several immune cell types, endothelial and epithelial ...
The function of the Interleukin-33 (IL-33)/ST2 system has been mainly investigated on immunological ...
(A) Treatment scheme for in vivo experiments. (B) Gating strategy to identify ILC2s. They were ident...
The role and effects of the IL-33/ST2 pathway in disease is still unknown. The work described here c...
<p>B6J-WT BMCMCs were stimulated with 0–1,000 ng/ml (A) or 100 ng/ml (B) rmIL-33 in the presence of ...
Similar abstract has been appporved for a conference (OAK22720). IL-33 binding to the receptor s...
<p>(A) IL-8 mRNA expression in HUVECs after treatment with the indicated concentrations of IL-33 (cl...
<p>(<i>A</i>) Total ST2 transcript levels were measured in primary HESC cultures treated with 8-brom...
The Suppression of Tumorigenicity 2 protein (ST2) is a member of the interleukin (IL) 1 receptor fam...
Interleukin 33 (IL-33), which is expressed by several immune cell types, endothelial and epithelial ...
<p>The HCECs were exposed to IL-33 (10 ng/ml) with prior incubation in the absence or presence of is...
IL-33 (interleukin 33) is type of cytokine designated an alarmin, which is released under stress con...
IL-33 is a type of cytokine and a new member of the IL-1 family labeled as an alarmin, which is rele...
<p>Infection induces the down-regulation of miR-203-3p in HSCs, resulting in the elevation of IL-33....
SOCS2 or SOCS1 was immunoprecipitated (I.P.) from whole-cell lysates, followed by Western blot analy...
Interleukin 33 (IL-33), which is expressed by several immune cell types, endothelial and epithelial ...
The function of the Interleukin-33 (IL-33)/ST2 system has been mainly investigated on immunological ...
(A) Treatment scheme for in vivo experiments. (B) Gating strategy to identify ILC2s. They were ident...
The role and effects of the IL-33/ST2 pathway in disease is still unknown. The work described here c...
<p>B6J-WT BMCMCs were stimulated with 0–1,000 ng/ml (A) or 100 ng/ml (B) rmIL-33 in the presence of ...
Similar abstract has been appporved for a conference (OAK22720). IL-33 binding to the receptor s...
<p>(A) IL-8 mRNA expression in HUVECs after treatment with the indicated concentrations of IL-33 (cl...
<p>(<i>A</i>) Total ST2 transcript levels were measured in primary HESC cultures treated with 8-brom...
The Suppression of Tumorigenicity 2 protein (ST2) is a member of the interleukin (IL) 1 receptor fam...
Interleukin 33 (IL-33), which is expressed by several immune cell types, endothelial and epithelial ...
<p>The HCECs were exposed to IL-33 (10 ng/ml) with prior incubation in the absence or presence of is...
IL-33 (interleukin 33) is type of cytokine designated an alarmin, which is released under stress con...
IL-33 is a type of cytokine and a new member of the IL-1 family labeled as an alarmin, which is rele...
<p>Infection induces the down-regulation of miR-203-3p in HSCs, resulting in the elevation of IL-33....
SOCS2 or SOCS1 was immunoprecipitated (I.P.) from whole-cell lysates, followed by Western blot analy...
Interleukin 33 (IL-33), which is expressed by several immune cell types, endothelial and epithelial ...
The function of the Interleukin-33 (IL-33)/ST2 system has been mainly investigated on immunological ...
(A) Treatment scheme for in vivo experiments. (B) Gating strategy to identify ILC2s. They were ident...